home / stock / cnsp / cnsp news


CNSP News and Press, CNS Pharmaceuticals Inc. From 06/05/23

Stock Information

Company Name: CNS Pharmaceuticals Inc.
Stock Symbol: CNSP
Market: NYSE
Website: cnspharma.com

Menu

CNSP CNSP Quote CNSP Short CNSP News CNSP Articles CNSP Message Board
Get CNSP Alerts

News, Short Squeeze, Breakout and More Instantly...

CNSP - GNPX, CNSP and SDA among pre-market losers

2023-06-05 08:14:50 ET Bellerophon Therapeutic ( BLPH ) -71% announces top-line data from phase 3 REBUILD clinical trial of INOpulse® for treatment of fibrotic interstitial lung disease. Mallinckrodt MNK -18% to consider filing for bankruptcy again - WSJ. ...

CNSP - Study Shows Brain Cancer Among Top Cancer Types in US

Prior studies have indicated that brain cancer occurs with more frequency in Northern Europe, North America and Australia with Russia, India, the United States, China and Brazil having the highest brain tumor mortality rates.  There has also been a significant increase in global brain and c...

CNSP - Proton Beam Therapy Could Boost Quality of Life for Cancer Patients

Cancer is still one of the most prolific killers in the world, accounting for one in every six deaths in 2020. Treatment outcomes often depend on the type of cancer and the speed with which it is diagnosed, with some types of cancer being relatively easy to treat and others having worse health...

CNSP - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves 50%+ Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”). The company today announced that its ongoing potentially pivotal study evaluatin...

CNSP - CNS Pharmaceuticals (NASDAQ:CNSP) Achieves Over 50% Completion of Enrollment in Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

Company continues to execute on rapid progression of enrollment toward planned interim analysis expected in the third quarter of 2023 45 clinical trial sites of the 60 sites selected across the U.S., Italy, France, Spain, and Switzerland open and enrolling patients HOUSTON, TX / ACCESSWI...

CNSP - Microbot Medical, Hepion Pharmaceuticals among healthcare gainers; Rain Oncology leads losers

2023-05-22 10:03:29 ET Gainers: Microbot Medical ( MBOT ) +46% . Hepion Pharmaceuticals ( HEPA ) +41% . Atea Pharmaceuticals ( AVIR ) +38% . VectivBio Holding ( VECT ) +37% . CNS Pharmaceuticals ( CNSP ) +23% . Losers: Rain Oncology ( ...

CNSP - CARM, CNSP and NBTX are among pre market gainers

2023-05-22 08:35:27 ET Greenhill & Co ( GHL ) +114% to Acquire Premier M&A Advisory Firm Greenhill. Hepion Pharmaceuticals ( HEPA ) +69% NASH candidate meets phase 2 goal; up 68%. VectivBio Holding ( VECT ) +39% falls 15% on deal to buy VectivBio for ...

CNSP - Notable Advancements Made in Research, Treatment of Brain Cancer

Brain cancer is an aggressive type of cancer that starts developing in the brain. There are many types of spinal cord and brain tumors, which can be either malignant or benign. Malignant brain tumors often grow and spread rather quickly into other tissues. The latest data from the National Canc...

CNSP - Researchers Find New Way to Detect Brain Tumors Using Urine Tests

Scientists have found a new way to detect tumors in the brain using a device that picks out a certain protein in the urine. This noninvasive method will eliminate the need for invasive tests while also increasing the chances of tumors being detected earlier. Glioblastoma multiforme is a commo...

CNSP - CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Enrollment in ongoing potentially pivotal study evaluating Berubicin for the treatment of GBM continues to rapidly progress toward planned interim analysis, expected in the third quarter of 2023 HOUSTON, TX / ACCESSWIRE / May 15, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or t...

Previous 10 Next 10